ESH Video

6th International Conference on Myeloproliferative Neoplasms

Chairs : T. Barbui , A. R. Green, R. Levine, H. L. Pahl, R. Skoda, W Vainchenker, A. Vannucchi

 

SESSION I:
Causes of myeloproliferative neoplasmsM.–F. McMullin

SESSION II:
Stem cell directed therapies for MPN patientsR. Hoffman
The Recql5 helicase, a novel downstream target of JAK2V617FA. Mullally
Haemostasis disorders in JAK2V617F knock-in miceJ.-L. Villeval
Prognostic impact of mutations in myelofibrosisA. Vannucchi

SESSION IV:
JAK-STAT signaling in MPNs
V. Sexl
Efficacy and toxicity of JAK inhibitorsC. Harrison
Conventional and newer prognostic factors in myelofibrosisF. Cervantes

SESSION V:
How do we achieve more meaningful responses to MPN therapy?R. Mesa
MPL/JAK2: from one signaling pathway to several disordersI. Plo

 



 
Clinical Updates on Acute Leukemias 6th International Conference on Myelodysplastic Syndromes ESH - GR-EX 2nd International Symposium on Red Blood Cells: Genesis and Pat...